Inhibition of ICAM1 diminishes stemness and enhances antitumor immunity in glioblastoma via β-catenin/PD-L1 signaling

Journal:

Nature Communications

Published:

2025-09-30

DOI:

10.1038/s41467-025-63796-2

Affiliations:

7

Authors:

11

Go to article

Institutions	Authors	Share
Henan University (HENU), China	4.166667	0.38
Henan-Macquarie University Joint Center for Biomedical Innovation, China	4.166667	0.38
Korea University, South Korea	1.000000	0.09
National Cancer Center (NCC), South Korea	1.000000	0.09
Macquarie University, Australia	0.333333	0.03
University of Technology Sydney (UTS), Australia	0.333333	0.03

Interested in Oncology and Carcinogenesis?